Enovix (ENVX) Projected to Announce Quarterly Earnings on Wednesday

Enovix (NASDAQ:ENVX) is expected to be announcing its Q2 2026 results after the market closes on Wednesday, August 12th. Analysts expect Enovix to announce earnings of ($0.14) per share and revenue of $8.4310 million for the quarter. Enovix has set its Q2 2026 guidance at -0.170–0.130 EPS. Investors may review the information on the company’s upcoming Q2 2026 earning report page for the latest details on the call scheduled for Wednesday, August 12, 2026 at 5:00 PM ET.

Enovix (NASDAQ:ENVX) last posted its earnings results on Wednesday, May 13th. The company reported ($0.14) earnings per share for the quarter, beating the consensus estimate of ($0.15) by $0.01. Enovix had a negative net margin of 499.64% and a negative return on equity of 64.28%. The firm had revenue of $7.60 million during the quarter, compared to the consensus estimate of $6.95 million. During the same period last year, the firm posted ($0.15) EPS. The firm’s revenue for the quarter was up 49.1% on a year-over-year basis. On average, analysts expect Enovix to post $-1 EPS for the current fiscal year and $-1 EPS for the next fiscal year.

Enovix Trading Down 1.3%

Shares of ENVX opened at $4.64 on Tuesday. The company has a debt-to-equity ratio of 2.14, a current ratio of 10.97 and a quick ratio of 10.65. Enovix has a 1-year low of $3.67 and a 1-year high of $14.21. The stock has a market cap of $1.01 billion, a price-to-earnings ratio of -5.59 and a beta of 2.32. The firm has a 50 day simple moving average of $5.61 and a 200-day simple moving average of $5.94.

Analyst Upgrades and Downgrades

Several brokerages have recently issued reports on ENVX. Oppenheimer reduced their price objective on Enovix from $24.00 to $21.00 and set an “outperform” rating on the stock in a research report on Thursday, May 14th. JPMorgan Chase & Co. downgraded shares of Enovix from a “neutral” rating to an “underweight” rating in a report on Wednesday, May 6th. Wall Street Zen raised shares of Enovix from a “strong sell” rating to a “sell” rating in a research report on Saturday, May 16th. TD Cowen decreased their target price on shares of Enovix from $7.00 to $5.50 and set a “hold” rating on the stock in a research report on Friday, July 24th. Finally, Benchmark cut their price target on Enovix from $25.00 to $15.00 and set a “buy” rating for the company in a report on Thursday, May 14th. Six equities research analysts have rated the stock with a Buy rating, two have assigned a Hold rating and two have assigned a Sell rating to the stock. According to MarketBeat, the company currently has an average rating of “Hold” and an average price target of $12.50.

Institutional Trading of Enovix

Institutional investors and hedge funds have recently bought and sold shares of the business. Cerity Partners LLC acquired a new position in shares of Enovix in the 4th quarter worth approximately $95,000. CIBC Bancorp USA Inc. acquired a new stake in Enovix in the third quarter worth $175,000. Mercer Global Advisors Inc. ADV bought a new position in shares of Enovix during the third quarter worth about $100,000. Focus Partners Wealth bought a new position in Enovix in the 3rd quarter worth approximately $170,000. Finally, Equitable Holdings Inc. raised its stake in Enovix by 10.9% during the 3rd quarter. Equitable Holdings Inc. now owns 13,700 shares of the company’s stock valued at $137,000 after acquiring an additional 1,342 shares in the last quarter. Institutional investors and hedge funds own 50.92% of the company’s stock.

Enovix Company Profile

Enovix Corporation (NASDAQ: ENVX) develops and manufactures advanced lithium-ion battery cells with a patented three-dimensional silicon-anode architecture. The company’s core focus is on delivering high energy density, improved safety, and longer cycle life compared to conventional graphite-based cells. Enovix’s technology targets a range of applications, including consumer electronics, wearable devices, electric vehicles and stationary energy storage systems.

Founded in 2011 and headquartered in Fremont, California, Enovix has built pilot production capability and is scaling up manufacturing capacity to meet growing demand.